The company maintains a conservative capital structure with a debt-to-equity ratio of 0.01 as of 2026Q1, providing a solid foundation despite the rapid expansion of total assets to $29.0 million.
| Total Current Assets | 22.09M | 16.16M | 10.78M | 6.86M | 25.43M |
| Cash & Short-Term Investments | 10.33M | 7.67M | 7.85M | 2.42M | 1.49M |
| Cash Only | 10.33M | 7.67M | 7.85M | 2.42M | 1.49M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.74M | 756.29K | 2.15M | 3.92M | 976.86K |
| Days Sales Outstanding | 38.47 | 8.28 | 40.21 | 74.65 | 61.8 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - |
| Other Current Assets | 8.02M | 7.73M | 787.16K | 526.15K | 22.96M |
| Total Non-Current Assets | 6.88M | 6.93M | 4.98M | 4.64M | 3.13M |
| Property, Plant & Equipment | 122.33K | 139.94K | 206.27K | 266.64K | 321.81K |
| Fixed Asset Turnover | 229.80x | 238.16x | 94.49x | 71.83x | 17.93x |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 3.96M | 3.56M | 2.76M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6.76M | 6.79M | 816K | 816K | 48.23K |
| Total Assets | 28.97M | 23.09M | 15.77M | 11.5M | 28.56M |
| Asset Turnover | 1.41x | 1.44x | 1.24x | 1.66x | 0.20x |
| Asset Growth % | 323.54% | 46.43% | 37.08% | -59.72% | - |
| Total Current Liabilities | 7.05M | 5.16M | 2.13M | 4.78M | 24.02M |
| Accounts Payable | 0 | 0 | 1.86M | 2.62M | 474.39K |
| Days Payables Outstanding | 56.23 | - | 167.47 | 415.23 | 518.13 |
| Short-Term Debt | 78.68K | 76.19K | 0 | 1.65M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.97M | 5.08M | 0 | 0 | 23.37M |
| Current Ratio | 3.13x | 3.13x | 5.06x | 1.43x | 1.06x |
| Quick Ratio | 3.13x | 3.13x | 5.06x | 1.43x | 1.06x |
| Cash Conversion Cycle | -17.76 | - | - | - | - |
| Total Non-Current Liabilities | 316.12K | 821.29K | 468.49K | 628.67K | 3.12M |
| Long-Term Debt | 42.91K | 63.62K | 0 | 0 | 0 |
| Capital Lease Obligations | 186.77K | 0 | 139.81K | 206.69K | 265.37K |
| Deferred Tax Liabilities | 1.57M | 757.67K | 328.68K | 421.98K | 288K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 2.57M |
| Total Liabilities | 7.36M | 5.98M | 2.6M | 5.41M | 27.14M |
| Total Debt | 121.59K | 139.81K | 206.69K | 1.92M | 316.09K |
| Net Debt | -10.2M | -7.53M | -7.64M | -501.18K | -1.17M |
| Debt / Equity | 0.01x | 0.01x | 0.02x | 0.31x | 0.22x |
| Debt / EBITDA | 2.11x | 0.06x | 0.14x | 0.51x | 1.54x |
| Net Debt / EBITDA | -176.88x | -3.10x | -4.99x | -0.13x | -5.70x |
| Interest Coverage | - | - | 2.80x | 1668.59x | 44.97x |
| Total Equity | 21.6M | 17.11M | 13.17M | 6.09M | 1.42M |
| Equity Growth % | 382.34% | 29.94% | 116.13% | 329.62% | - |
| Book Value per Share | 0.38 | 0.30 | 0.25 | 0.11 | 0.03 |
| Total Shareholders' Equity | 21.6M | 17.11M | 13.17M | 6.09M | 1.05M |
| Common Stock | 65.56K | 57.71K | 54.62K | 51.77K | 45K |
| Retained Earnings | 3.63M | 5.22M | 3.94M | 3.27M | 794.26K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 367.77K |
Liquidity constraints from scaling
According to the provided quarterly balance sheets, total assets grew from $11.5 million in 2023Q4 to $29.0 million by 2026Q1, reflecting a rapid expansion phase that appears to be driven by aggressive investment in the company's proprietary eDIYBS quoting engine and broader market penetration efforts.
The consistent growth in total assets suggests that the company is successfully deploying capital to scale its infrastructure, though this trajectory is increasingly reliant on external funding or retained earnings. Investors should monitor whether this asset growth translates into sustainable long-term competitive advantages or if it merely reflects the high cost of maintaining a complex, service-heavy insurance platform.
Based on reported financial statements, the company maintains a conservative capital structure with a debt-to-equity ratio of 0.01% as of 2026Q1, indicating that management has largely avoided debt-based financing to fund its rapid growth, thereby preserving significant balance sheet flexibility for future operational needs.
The near-zero debt profile suggests that the firm is currently prioritizing equity-based growth, which mitigates immediate refinancing risks but may limit the company's ability to leverage its balance sheet for inorganic expansion. This reliance on equity suggests that shareholders should remain cautious regarding potential dilution if the company requires additional capital to sustain its current growth trajectory.
As reported in recent filings, the current ratio has fluctuated significantly, settling at 3.13 in 2026Q1, which provides a temporary liquidity buffer, yet the absolute cash position of $10.3 million may prove insufficient if the current rate of cash burn continues to accelerate alongside operational expansion.
While the current ratio appears healthy on the surface, the underlying cash position relative to the company's aggressive growth strategy warrants close scrutiny. The volatility in liquidity metrics suggests that the firm's ability to meet short-term obligations could be tested if revenue growth fails to offset the rising costs of claims advocacy and network management.
Based on the provided data, equity has increased from $6.1 million in 2023Q4 to $21.6 million in 2026Q1, a trend that appears to be driven by the accumulation of retained earnings and potential capital injections, though the quality of this equity remains subject to future operational performance.
The growth in equity provides a solid foundation for the company's ongoing operations, yet the reliance on retained earnings to bolster the balance sheet implies that profitability is critical for long-term stability. Analysts should monitor whether future equity growth is driven by organic earnings or if the company will need to rely on further share issuance to maintain its current pace.
Quick answers to the most common questions about buying HIT stock.
As of 2025, Health In Tech, Inc. (HIT) had total assets of $23.1M including $16.2M in current assets.
Health In Tech, Inc. (HIT) carries total debt of $0.1M, offset by $7.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Health In Tech, Inc. (HIT) has total shareholders' equity (book value) of $17.1M ($0.30 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Health In Tech, Inc. (HIT) reported a current ratio of 3.13x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.